These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33677869)

  • 1. [Expression of iron-regulating erythroid factors in different types of erythropoiesis disorders].
    Liu X; Hu J; Hu XR; Li XX; Guan DR; Liu JQ; Zhang YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):52-57. PubMed ID: 33677869
    [No Abstract]   [Full Text] [Related]  

  • 2. [GDF11 level in patients with myelodysplastic syndrome and its clinical significance].
    Han Y; Wang H; Fu R; Qu W; Ruan E; Wang X; Wang G; Wu Y; Liu H; Song J; Guan J; Xing L; Li L; Jiang H; Liu H; Wang Y; Liu C; Zhang W; Shao Z
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(8):620-4. PubMed ID: 26932855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.
    Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM
    PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High erythroferrone expression in CD71
    Riabov V; Mossner M; Stöhr A; Jann JC; Streuer A; Schmitt N; Knaflic A; Nowak V; Weimer N; Obländer J; Palme I; Schumann C; Baldus CD; Schulze TJ; Wuchter P; Röhl H; Jawhar A; Weiss C; Boch T; Metzgeroth G; Neumann M; Hofmann WK; Nolte F; Nowak D
    Br J Haematol; 2021 Mar; 192(5):879-891. PubMed ID: 33486765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
    Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
    Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression.
    Fang Z; Zhu Z; Zhang H; Peng Y; Liu J; Lu H; Li J; Liang L; Xia S; Wang Q; Fu B; Wu K; Zhang L; Ginzburg Y; Liu J; Chen H
    Br J Haematol; 2020 Jan; 188(2):321-331. PubMed ID: 31418854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant erythroferrone disrupts iron homeostasis in
    Bondu S; Alary AS; Lefèvre C; Houy A; Jung G; Lefebvre T; Rombaut D; Boussaid I; Bousta A; Guillonneau F; Perrier P; Alsafadi S; Wassef M; Margueron R; Rousseau A; Droin N; Cagnard N; Kaltenbach S; Winter S; Kubasch AS; Bouscary D; Santini V; Toma A; Hunault M; Stamatoullas A; Gyan E; Cluzeau T; Platzbecker U; Adès L; Puy H; Stern MH; Karim Z; Mayeux P; Nemeth E; Park S; Ganz T; Kautz L; Kosmider O; Fontenay M
    Sci Transl Med; 2019 Jul; 11(500):. PubMed ID: 31292266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into iron regulation and erythropoiesis.
    Kim A; Nemeth E
    Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.
    Suragani RN; Cadena SM; Cawley SM; Sako D; Mitchell D; Li R; Davies MV; Alexander MJ; Devine M; Loveday KS; Underwood KW; Grinberg AV; Quisel JD; Chopra R; Pearsall RS; Seehra J; Kumar R
    Nat Med; 2014 Apr; 20(4):408-14. PubMed ID: 24658078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.
    Tanno T; Porayette P; Sripichai O; Noh SJ; Byrnes C; Bhupatiraju A; Lee YT; Goodnough JB; Harandi O; Ganz T; Paulson RF; Miller JL
    Blood; 2009 Jul; 114(1):181-6. PubMed ID: 19414861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
    Srole DN; Ganz T
    J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.
    Wang C; Fang Z; Zhu Z; Liu J; Chen H
    Exp Hematol; 2017 Aug; 52():24-31. PubMed ID: 28501597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal range and predictors of serum erythroferrone in infants.
    Bäckström F; Chmielewska A; Domellöf M; Berglund SK
    Pediatr Res; 2023 Sep; 94(3):965-970. PubMed ID: 37069224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
    Olivera J; Zhang V; Nemeth E; Ganz T
    Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias.
    Ozturk Z; Gumuslu S; Yalcin K; Kupesiz A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):186-192. PubMed ID: 34157011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
    Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
    Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
    Youssry I; Samy RM; AbdelMohsen M; Salama NM
    Pediatr Res; 2024 Mar; 95(4):1095-1100. PubMed ID: 37464096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of iron overload in myelodysplastic syndromes and other bone marrow failure syndromes].
    Kobune M
    Rinsho Ketsueki; 2020; 61(7):753-763. PubMed ID: 32759562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.